ETP-ALL with aberrant B marker expression: Case series and a brief review of literature
Shikha Garg
Lab Oncology Unit, Dr BRA IRCH, All India Institute of Medical Sciences (AIIMS), New Delhi, India
Search for more papers by this authorCorresponding Author
Sanjeev Kumar Gupta
Lab Oncology Unit, Dr BRA IRCH, All India Institute of Medical Sciences (AIIMS), New Delhi, India
Correspondence
Sanjeev Kumar Gupta, Lab Oncology Unit, Dr BRA IRCH, All India Institute of Medical Sciences (AIIMS), Ansari Nagar, New Delhi, India.
Emails: [email protected]; [email protected]
Search for more papers by this authorSameer Bakhshi
Department of Medical Oncology, Dr BRA IRCH, All India Institute of Medical Sciences (AIIMS), New Delhi, India
Search for more papers by this authorSaumyaranjan Mallick
Department of Pathology, All India Institute of Medical Sciences (AIIMS), New Delhi, India
Search for more papers by this authorLalit Kumar
Department of Medical Oncology, Dr BRA IRCH, All India Institute of Medical Sciences (AIIMS), New Delhi, India
Search for more papers by this authorShikha Garg
Lab Oncology Unit, Dr BRA IRCH, All India Institute of Medical Sciences (AIIMS), New Delhi, India
Search for more papers by this authorCorresponding Author
Sanjeev Kumar Gupta
Lab Oncology Unit, Dr BRA IRCH, All India Institute of Medical Sciences (AIIMS), New Delhi, India
Correspondence
Sanjeev Kumar Gupta, Lab Oncology Unit, Dr BRA IRCH, All India Institute of Medical Sciences (AIIMS), Ansari Nagar, New Delhi, India.
Emails: [email protected]; [email protected]
Search for more papers by this authorSameer Bakhshi
Department of Medical Oncology, Dr BRA IRCH, All India Institute of Medical Sciences (AIIMS), New Delhi, India
Search for more papers by this authorSaumyaranjan Mallick
Department of Pathology, All India Institute of Medical Sciences (AIIMS), New Delhi, India
Search for more papers by this authorLalit Kumar
Department of Medical Oncology, Dr BRA IRCH, All India Institute of Medical Sciences (AIIMS), New Delhi, India
Search for more papers by this author
REFERENCES
- 1Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia. Blood. 2016; 127(20): 2391-2405.
- 2Coustan-Smith E, Mullighan CG, Onciu M, et al. Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. Lancet oncol. 2009; 10(2): 147-156.
- 3Inukai T, Kiyokawa N, Campana D, et al. Clinical significance of early T-cell precursor acute lymphoblastic leukaemia: results of the Tokyo Children's Cancer Study Group Study L99-15. Br J Haematol. 2012; 156: 358-365.
- 4Ma M, Wang X, Tang J, et al. Early T-cell precursor leukemia: a sub-type of high risk childhood acute lymphoblastic leukemia. Front Med. 2012; 6: 416-420.
- 5Jain N, Lamb AV, O'Brien S, et al. Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype. Blood. 2016; 127(15): 1863-1869.
- 6Pomerantz A, Rodriguez-Rodriguez S, Demichelis-Gomez R, et al. Mixed-phenotype acute leukemia: suboptimal treatment when the 2008/2016 WHO classification is used. Blood Res. 2016; 51(4): 233-241.
- 7Luc S, Luis TC, Boukarabila H, et al. The earliest thymic T cell progenitors sustain B cell and myeloid lineage potential. Nat Immunol. 2012; 13(4): 412.
- 8Benz C, Bleu CC. A multipotent precursor in the thymus maps to the branching point of the T versus B lineage decision. J Exp Med. 2005; 202: 21-31.
- 9Donskoy E, Goldschneider I. Thymocytopoiesis is maintained by blood-borne precursors throughout postnatal life. A study in parabiotic mice. J Immunol. 1992; 148(6): 1604-1612.
- 10Bhandoola A, von Boehmer H, Petrie HT, Zuniga-Pflucker JC. Commitment and developmental potential of extrathymic and intrathymic T cell precursors: plenty to choose from. Immunity. 2007; 26: 678-689.
- 11Bell JJ, Bhandoola A. The earliest thymic progenitors for T cells possess myeloid lineage potential. Nature. 2008; 452: 764-767.
- 12Orkin SH, Zon LI. Hematopoiesis: an evolving paradigm for stem cell biology. Cell. 2008; 132: 631-644.
- 13Kawamoto H, Katsura Y. A new clonal assay system for lymphoid and myeloid lineages. Methods Mol Med. 2004; 105: 345-357.
- 14Balciunaite G, Ceredig R, Rolink AG. The earliest subpopulation of mouse thymocytes contains potent T, significant macrophage, and natural killer cell but no B-lymphocyte potential. Blood. 2005; 105: 1930-1936.
- 15Porritt HE, Rumfelt LL, Tabrizifard S, et al. Heterogeneity among DN1 prothymocytes reveals multiple progenitors with different capacities to generate T cell and non-T cell lineages. Immunity. 2004; 20: 735-745.
- 16Allen A, Sireci A, Colovai A, et al. Early T-cell precursor leukemia/lymphoma in adults and children. Leuk Res. 2013; 37: 1027-1034.
- 17Neumann M, Heesch S, Gökbuget N. Clinical and molecular characterization of early T-cell precursor leukemia: a high-risk subgroup in adult T-ALL with a high frequency of FLT3 mutations. Blood Cancer J. 2012; 2(1): e55.
Citing Literature
